“…IFN-γ is a major activator of various types of immune cells (Wakita et al, 2009;Hayakawa et al, 2011) and also can induce the expression of the major histocompatibility complex in both normal and malignant cells and provokes inflammatory 1 infiltrate infiltration (Chen et al, 2012;Hong et al, 2014). In addition, IFN-γ can directly inhibit the growth of cells, in some cases, through the induction of cell cycle arrest with or without the concomitant induction of apoptosis (Tate et al, 2012;Liu et al, 2012;Jin et al, 2013;Zhao et al, 2013Wang, 2014. Recognition of the direct antiproliferative properties of IFN-γ and its ability to stimulate the immune system has led to the investigation of its therapeutic activity in a number of malignant conditions.…”